We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Unwanted Heparin Removed from Blood

By HospiMedica International staff writers
Posted on 11 Nov 2008
A new approach for removing unwanted heparin from blood involves the use of microscopic beads of a polymer made from chitosan, a material obtained from shellfish. More...


Polymeric microspheres were obtained by the cross-linking of chitosan using genipin. In laboratory tests, the beads reduced concentrations of heparin to nearly zero within 10 minutes.

A main advantage of the polymeric system is that all of the basic reagents used to prepare the microspheres (chitosan, genipin, and surfactants) are inexpensive and nontoxic. The rate of heparin removal can be adjusted by changing the pH in a wide range. In order to enable heparin removal at higher pH values, cationically-modified chitosan microspheres resulted in a high rate of heparin removal, even at the pH value that is typical of blood (circa 7.4)--this enables even more medical applications of the polymer.

Doctors frequently need to remove heparin from the blood of patients who have undergone surgery or other procedures immediately after completing the procedure. If this is not done the heparin alone could lead to unwanted bleeding. Currently patients are given protamine, a drug that stops heparin's anticoagulant effects. However, protamine itself can cause serious adverse effects

The new polymer material was described by Krzysztof Szczubialka Ph.D., from the Jagiellonian University (Krakow, Poland), and colleagues in the December 8, 2008 issue of the American Chemical Society journal Biomacromolecules.

Related Links:
Jagiellonian University




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.